|
Market Closed -
Swiss Exchange
11:30:33 2026-08-17 EDT
|
5-day change | 1st Jan Change | ||
| 71.80 CHF | 0.00% |
|
-1.91% | -16.90% |
| 08-20 | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
| 08-20 | Cancer vaccines finally garner the spotlight |  |
| Market Cap | 93.2B 109B 87.2B 79.82B 150B 10,410B 152B 1,030B 402B 5,229B 409B 400B 17,297B | P/E 2026 * |
12.5x | P/E 2027 * | 11x |
|---|---|---|---|---|---|
| Enterprise Value | 105B 122B 97.88B 89.6B 168B 11,685B 170B 1,156B 451B 5,870B 459B 449B 19,415B | EV / Sales 2026 * |
2.2x | EV / Sales 2027 * | 2x |
| Free-Float |
88.34% | Yield 2026 * |
5.39% | Yield 2027 * | 5.7% |
Last Transcript: Sanofi
| 1 week | -1.91% | ||
| Current month | -1.91% | ||
| 1 month | -1.91% | ||
| 3 months | -1.91% | ||
| 6 months | -16.90% | ||
| Current year | -16.90% |
| 1 week | 71.8 |  | 71.8 |
| 1 month | 71.8 | | 73.2 |
| Current year | 71.8 | | 73.2 |
| 1 year | 71.8 | | 73.2 |
| 3 years | 71.8 | | 73.2 |
| 5 years | 71.8 | | 73.2 |
| 10 years | 71.8 | | 100 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Houman Ashrafian
CTO | Chief Tech/Sci/R&D Officer | 51 | 2023-09-10 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 57 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 65 | 2020-04-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -1.91% | - | - | 109B | |
| +0.88% | +6.38% | +76.86% | +128.23% | 1,109B | |
| +1.07% | +3.80% | +51.03% | +61.48% | 644B | |
| +1.20% | +6.21% | +26.47% | +76.45% | 463B | |
| +1.02% | +3.67% | +43.14% | +47.27% | 371B | |
| +0.85% | +2.97% | +24.48% | +42.54% | 301B | |
| +1.26% | +4.54% | +2.20% | +14.84% | 256B | |
| +1.88% | +5.81% | +48.54% | +68.52% | 234B | |
| +1.59% | +0.87% | -12.95% | -51.91% | 205B | |
| +1.87% | +5.61% | +25.81% | +92.42% | 178B | |
| Average | +1.04% | +3.00% | +31.73% | +53.32% | 417.9B | |
| Weighted average by Cap. | +1.03% | +3.26% | +44.58% | +72.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.59B 55.56B 44.53B 40.76B 76.5B 5,316B 77.51B 526B 205B 2,670B 209B 204B 8,833B | 50.7B 59.19B 47.44B 43.43B 81.5B 5,663B 82.58B 561B 219B 2,845B 222B 217B 9,410B |
| Net income | 7.94B 9.27B 7.43B 6.8B 12.76B 887B 12.93B 87.79B 34.23B 446B 34.81B 34.05B 1,474B | 9.27B 10.82B 8.67B 7.94B 14.9B 1,035B 15.09B 102B 39.95B 520B 40.62B 39.74B 1,720B |
| Net Debt | 11.42B 13.33B 10.68B 9.78B 18.35B 1,275B 18.59B 126B 49.21B 641B 50.04B 48.95B 2,119B | 8.23B 9.61B 7.7B 7.05B 13.23B 920B 13.41B 91.01B 35.49B 462B 36.09B 35.3B 1,528B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-20 | CHF 71.80 | 0.00% | 550 |
| 26-08-19 | CHF 71.80 | 0.00% | 0 |
| 26-08-18 | CHF 71.80 | 0.00% | 320 |
| 26-08-17 | CHF 71.80 | -1.91% | 150 |
| 26-08-14 | CHF 73.20 | 0.00% | 0 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
- SAN Stock
Select your edition
All financial news and data tailored to specific country editions
